PRESS RELEASE published on 07/15/2024 at 08:15, 1 year 9 months ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer Nyxoah appoints Scott Holstine as Chief Commercial Officer, bringing 26 years of medical device industry experience. His role is crucial for Nyxoah's U.S. launch success in treating Obstructive Sleep Apnea Chief Commercial Officer Medical Technology Nyxoah Obstructive Sleep Apnea Scott Holstine
BRIEF published on 07/03/2024 at 12:35, 1 year 10 months ago Nyxoah signe un accord de prêt de 37,5 millions d'euros avec la Banque européenne d'investissement Technologie Médicale Accord De Prêt Banque Européenne D'investissement Nyxoah Apnée Obstructive Du Sommeil
BRIEF published on 07/03/2024 at 12:35, 1 year 10 months ago Nyxoah Signs €37.5 Million Loan Agreement with European Investment Bank Loan Agreement Medical Technology European Investment Bank Nyxoah Obstructive Sleep Apnea
PRESS RELEASE published on 07/03/2024 at 12:30, 1 year 10 months ago Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Nyxoah signs a €37.5 million loan facility agreement with the European Investment Bank to boost research, development, and manufacturing capacity for sleep apnea solutions Research And Development European Investment Bank Sleep Apnea Nyxoah €37.5 Million Loan
Published on 05/09/2026 at 01:30, 18 hours 24 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 19 hours 54 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 49 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 23 hours 16 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
